Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers

Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X:

“More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers, including Antonio Giordano presenting on the Nectin4 ADC enfortumab vedotin for metastatic breast cancer and Ana Garrido-Castro presenting the first randomized Topo1 ADC-IO trial in breast oncology!” .

Quoting Dana-Farber Cancer Institute’s post:

“Heading to ASCO24? There are more than 25 oral presentations that are Dana-Farber researcher lead. Check out the list and follow Dana Farber News for full conference coverage.”

Source: Paolo Tarantino/X and Dana-Farber Cancer Institute/X